Pediatric Patients with CGvHD Ibrutinib OK’d by FDA Â Chronic graft versus host disease, or CGvHD, is a condition associated…
Browsing: Pediatric
Peter Cole, MD, Rutgers Cancer Institute of New Jersey Embrace Kids Foundation Endowed Chair in Pediatric Hematology/Oncology and Chief of…
Peter Cole, MD, Rutgers Cancer Institute of New Jersey Embrace Kids Foundation Endowed Chair in Pediatric Hematology/Oncology and Chief of…
Brigitte Widemann, MD, Deputy Director, Center for Cancer Research, National Cancer Institute speaks about Selumetinib in Children with Inoperable Plexiform…
Brigitte C. Widemann, MD and Andrea Gross, MD of National Cancer Institute discuss selumetinib, the first medicine approved to treat…
Brigitte C. Widemann, MD and Andrea Gross, MD of National Cancer Institute discuss selumetinib, the first medicine approved to treat…
Brigitte C. Widemann, MD and Andrea Gross, MD of National Cancer Institute discuss selumetinib, the first medicine approved to treat…